Theraclion S.A. (TCLIF) Research

Theraclion SA specializes in developing advanced echotherapy devices that harness high-intensity focused ultrasound technology. Its product portfolio includes SONOVEIN, a robotic, non-surgical echotherapy system specifically designed for treating varicose veins. Another key offering is ECHOPULSE, also a robotic and non-invasive echotherapy solution, utilized for addressing thyroid nodules and breast fibroadenomas. The company further provides EPack, a disposable accessory that attaches to the treatment device to ensure patient skin protection and improve imaging precision. Founded in 2004, Theraclion SA is headquartered in Malakoff, France.

Market snapshot

Symbol
TCLIF
Price
$0.53
Day change
0.00%
Market cap
$33.0M
P/E ratio
-7.15x
52-week range
0.00017-0.59
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 4 months

Peer companies

  • Accelera Innovations, Inc (ACNV)
  • Acutus Medical, Inc. (AFIB)
  • Aridis Pharmaceuticals, Inc. (ARDS)
  • Biostax Corp. (BTAX)
  • Capital Group Holdings, Inc. (CGHC)
  • Ingen Technologies, Inc. (IGNT)
  • ChromoCure, Inc. (KKUR)
  • SES Solar Inc. (SESI)

Open Theraclion S.A. (TCLIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.